Speaker Profile

MPH, M.D., Chief Medical Officer, Verily
Biography

Jessica L. Mega, MD, MPH, is the Chief Medical Officer at Verily Life Sciences. As a faculty member at Harvard Medical School (on leave), a senior investigator with the TIMI Study Group, and a cardiologist at Brigham and Women’s Hospital, she led large, international, randomized trials evaluating novel cardiovascular therapies. She also directed the TIMI Study Group’s Genetics Program. Her research findings have been published in the New England Journal of Medicine, Lancet, JAMA, and elsewhere. Dr. Mega is a graduate of Stanford University, Yale University School of Medicine and Harvard School of Public Health. She completed Internal Medicine Residency at Brigham and Women’s Hospital and Cardiovascular Fellowship at Massachusetts General Hospital. She is board certified in Internal Medicine and Cardiology. She has won the Laennec Society, Samuel A. Levine, and Douglas P. Zipes Awards, and she is a Fellow of the American Heart Association (AHA) and the American College of Cardiology (ACC).

Session Abstract – PMWC 2019 Silicon Valley

Session Synopsis: Data-driven innovations are transforming every facet of our lives – most notably, healthcare and the life sciences. Big data and advanced analytics are powering the next great industrial revolution. The promise and potential are enormous: from novel medicines to better prediction of disease to selection of better interventions. Big data approaches have also been the subject of much hype and skepticism. This panel brings together leaders from biotech, venture capital, big data, AI and ML to debate the success, potential, and limitations of big data in providing solutions to some the biggest challenges facing us in healthcare today.

Don't Miss Important Precision Medicine Updates

PMWC is the most comprehensive precision medicine conference. To receive the lastest news and updates from the field, subscribe to the newsletter here.

You have Successfully Subscribed!